Showing 4551-4560 of 23276 results for "".
Conference Coverage Highlights: American Society of Clinical Oncology
https://reachmd.com/programs/conference-coverage/conference-coverage-highlights-american-society-of-clinical-oncology/4697/Join us for highlights from the American Society of Clinical Oncology's 45th annual meeting, which took place May 29th through June 2nd, 2009, in Orlando, Florida.FDA: Advisory on Body Building Products
https://reachmd.com/programs/FDA-Drug-Information-Updates/fda-advisory-on-body-building-products/4649/On July 28th, 2009, the FDA issued an advisory recommending that consumers do not use body building products marketed as containing steroids or steroid-like substances, due to potential serious health risks. Listen now for the full advisory.Conference Coverage Highlights: American Diabetes Association
https://reachmd.com/programs/conference-coverage/conference-coverage-highlights-american-diabetes-association/4638/Join us for research highlights from the American Diabetes Association's 69th Scientific Sessions. This meeting took place June 5th through 9th, in New Orleans.Highlights from the 2009 AAAAI Annual Meeting
https://reachmd.com/programs/conference-coverage/highlights-from-the-2009-aaaai-annual-meeting/4370/Join us for research presented at the 2009 meeting of the American Academy of Allergy, Asthma & Immunology, held March 13th through the 17th in Washington, DC.Key Concerns When Administering Meds Via a Feeding Tube
https://reachmd.com/programs/focus-on-pharmacy/key-concerns-when-administering-meds-via-a-feeding-tube/4270/For patients who are unable to receive nutrition or medications orally, enteral feeding tubes offer one alternative method of delivery. Successful administration through a feeding tube requires awareness of potential problems with drug efficacy, adverse symptoms or a clogged tube. Dr. Nancy ToedterThe Human Toll of South Africa's Early AIDS Policies
https://reachmd.com/programs/focus-on-global-medicine/the-human-toll-of-south-africas-early-aids-policies/4228/Dr. Pride Chigwedere, an affiliate of the Harvard AIDS Initiative, speaks with host Dr. Cathleen Margolin about the role of government policy in the AIDS epidemic in South Africa. Dr. Chigwedere's research, as published in the Journal of Acquired Immune Deficiency Syndromes, pins fault on these frigRationales for Uterine Artery Embolization for Fibroids
https://reachmd.com/programs/advances-in-medical-imaging/rationales-for-uterine-artery-embolization-for-fibroids/4204/Host Dr. Jason Birnholz and Dr. James Spies, professor of radiology at Georgetown University and chairman of the department of radiology at Georgetown University Medical Center, look at fibroid tumors- their incidence and treatment. They discuss the populations in which there is a high prevalence, aResearching Ways to Treat Aortic Stenosis
https://reachmd.com/programs/focus-on-heart-health/researching-ways-to-treat-aortic-stenosis/4160/Aortic stenosis is a disease that impacts heart valves but is often very difficult to treat in elderly and very sick patients. Dr. William Fearon, assistant professor of cardiovascular medicine at the Stanford University School of Medicine, tells host Bruce Japsen about work being done to improve trAddressing Hyporesponsiveness to Erythropoetic Therapy
https://reachmd.com/programs/focus-on-pharmacy/addressing-hyporesponsiveness-to-erythropoetic-therapy/3233/How can we optimize erythropoetic therapy in patients with anemia of chronic kidney disease? How widespread is the problem of hyporesponsiveness to erythropoetic-stimulating agents? Dr. Sarah Tomasello, clinical associate professor at the Ernest Mario School of Pharmacy at Rutgers, the State UniversOral Chemotherapeutic Agents: How Have They Transformed Pharmacy and Oncology?
https://reachmd.com/programs/focus-on-pharmacy/oral-chemotherapeutic-agents-how-have-they-transformed-pharmacy-and-oncology/2692/How do oral chemotherapeutic agents work, and what advances are needed to better optimize oncologic pharmacotherapy? Dr. Susan Goodin, oncology pharmacist and director of the Division of Pharmaceutical Services at the Cancer Institute of New Jersey, speaks with host Dr. Charles Turck on these import